Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Antibody-mediated Inflammatory Responses by Macrophages in Individuals With and Without Obesity

NCT06968442 is registered in ClinicalTrials.gov with Franciscus Gasthuis as lead sponsor.

NCT NCT06968442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06968442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Antibody-mediated Inflammatory Responses by Macrophages in Individuals With and Without Obesity
Lead sponsor
Franciscus Gasthuis
Phase
Not applicable
Overall status
Recruiting
Start date
April 22, 2025
Completion date
April 22, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody covid-19, covid-19